Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The need for treatment interruption studies and biomarker identification in the search for an HIV cure.

Literature DB >> 25870989

The need for treatment interruption studies and biomarker identification in the search for an HIV cure.

Jonathan Z Li¹, Davey M Smith, John W Mellors.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 25870989 PMCID： PMC4529360 DOI： 10.1097/QAD.0000000000000658

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

× No keyword cloud information.

28 in total

Review 1. Unravelling the mechanisms of durable control of HIV-1.

Authors: Bruce D Walker; Xu G Yu
Journal: Nat Rev Immunol Date: 2013-07 Impact factor: 53.106

2. Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption.

Authors: Meghan K Rothenberger; Brandon F Keele; Stephen W Wietgrefe; Courtney V Fletcher; Gregory J Beilman; Jeffrey G Chipman; Alexander Khoruts; Jacob D Estes; Jodi Anderson; Samuel P Callisto; Thomas E Schmidt; Ann Thorkelson; Cavan Reilly; Katherine Perkey; Thomas G Reimann; Netanya S Utay; Krystelle Nganou Makamdop; Mario Stevenson; Daniel C Douek; Ashley T Haase; Timothy W Schacker
Journal: Proc Natl Acad Sci U S A Date: 2015-02-23 Impact factor: 11.205

3. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.

Authors: Timothy J Henrich; Emily Hanhauser; Francisco M Marty; Michael N Sirignano; Sheila Keating; Tzong-Hae Lee; Yvonne P Robles; Benjamin T Davis; Jonathan Z Li; Andrea Heisey; Alison L Hill; Michael P Busch; Philippe Armand; Robert J Soiffer; Marcus Altfeld; Daniel R Kuritzkes
Journal: Ann Intern Med Date: 2014-09-02 Impact factor: 25.391

4. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection.

Authors: R Colven; R D Harrington; D H Spach; C J Cohen; T M Hooton
Journal: Ann Intern Med Date: 2000-09-19 Impact factor: 25.391

5. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors: Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal: N Engl J Med Date: 2014-03-06 Impact factor: 91.245

6. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation.

Authors: Timothy J Henrich; Zixin Hu; Jonathan Z Li; Gaia Sciaranghella; Michael P Busch; Sheila M Keating; Sebastien Gallien; Nina H Lin; Francoise F Giguel; Laura Lavoie; Vincent T Ho; Philippe Armand; Robert J Soiffer; Manish Sagar; Ann S Lacasce; Daniel R Kuritzkes
Journal: J Infect Dis Date: 2013-03-04 Impact factor: 5.226

7. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.

Authors: Asier Sáez-Cirión; Charline Bacchus; Laurent Hocqueloux; Véronique Avettand-Fenoel; Isabelle Girault; Camille Lecuroux; Valerie Potard; Pierre Versmisse; Adeline Melard; Thierry Prazuck; Benjamin Descours; Julien Guergnon; Jean-Paul Viard; Faroudy Boufassa; Olivier Lambotte; Cécile Goujard; Laurence Meyer; Dominique Costagliola; Alain Venet; Gianfranco Pancino; Brigitte Autran; Christine Rouzioux
Journal: PLoS Pathog Date: 2013-03-14 Impact factor: 6.823

8. Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.

Authors: Datsen George Wei; Vicki Chiang; Elizabeth Fyne; Mini Balakrishnan; Tiffany Barnes; Michael Graupe; Joseph Hesselgesser; Alivelu Irrinki; Jeffrey P Murry; George Stepan; Kirsten M Stray; Angela Tsai; Helen Yu; Jonathan Spindler; Mary Kearney; Celsa A Spina; Deborah McMahon; Jacob Lalezari; Derek Sloan; John Mellors; Romas Geleziunas; Tomas Cihlar
Journal: PLoS Pathog Date: 2014-04-10 Impact factor: 6.823

9. New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.

Authors: C Korin Bullen; Gregory M Laird; Christine M Durand; Janet D Siliciano; Robert F Siliciano
Journal: Nat Med Date: 2014-03-23 Impact factor: 53.440

10. HIV-1 DNA predicts disease progression and post-treatment virological control.

Authors: James P Williams; Jacob Hurst; Wolfgang Stöhr; Nicola Robinson; Helen Brown; Martin Fisher; Sabine Kinloch; David Cooper; Mauro Schechter; Giuseppe Tambussi; Sarah Fidler; Mary Carrington; Abdel Babiker; Jonathan Weber; Kersten K Koelsch; Anthony D Kelleher; Rodney E Phillips; John Frater
Journal: Elife Date: 2014-09-12 Impact factor: 8.140

38 in total

Review 1. Post-Treatment Controllers: Role in HIV "Cure" Research.

Authors: Leslie R Cockerham; Hiroyu Hatano; Steven G Deeks
Journal: Curr HIV/AIDS Rep Date: 2016-02 Impact factor: 5.071

2. Human Immunodeficiency Virus Transmission Risk in Analytical Treatment Interruption Studies: Relational Factors and Moral Responsibility.

Authors: Liza Dawson
Journal: J Infect Dis Date: 2019-07-02 Impact factor: 5.226

3. Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.

Authors: Graham C Treasure; Evgenia Aga; Ronald J Bosch; John W Mellors; Daniel R Kuritzkes; Michael Para; Rajesh T Gandhi; Jonathan Z Li
Journal: J Acquir Immune Defic Syndr Date: 2016-07-01 Impact factor: 3.731

4. "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.

Authors: Karine Dubé; David Evans; Lynda Dee; Laurie Sylla; Jeff Taylor; Asheley Skinner; Bryan J Weiner; Sandra B Greene; Stuart Rennie; Joseph D Tucker
Journal: AIDS Res Hum Retroviruses Date: 2017-07-10 Impact factor: 2.205

5. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.

Authors: Golnaz Namazi; Jesse M Fajnzylber; Evgenia Aga; Ronald J Bosch; Edward P Acosta; Radwa Sharaf; Wendy Hartogensis; Jeffrey M Jacobson; Elizabeth Connick; Paul Volberding; Daniel Skiest; David Margolis; Michael C Sneller; Susan J Little; Sara Gianella; Davey M Smith; Daniel R Kuritzkes; Roy M Gulick; John W Mellors; Vikram Mehraj; Rajesh T Gandhi; Ronald Mitsuyasu; Robert T Schooley; Keith Henry; Pablo Tebas; Steven G Deeks; Tae-Wook Chun; Ann C Collier; Jean-Pierre Routy; Frederick M Hecht; Bruce D Walker; Jonathan Z Li
Journal: J Infect Dis Date: 2018-11-05 Impact factor: 5.226

10. Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART.

Authors: Alexander O Pasternak; Marlous L Grijsen; Ferdinand W Wit; Margreet Bakker; Suzanne Jurriaans; Jan M Prins; Ben Berkhout
Journal: JCI Insight Date: 2020-03-26